Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Current Assets (2016 - 2025)

Mimedx (MDXG) has disclosed Current Assets for 15 consecutive years, with $277.5 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 44.6% to $277.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $277.5 million through Dec 2025, up 44.6% year-over-year, with the annual reading at $277.5 million for FY2025, 44.6% up from the prior year.
  • Current Assets hit $277.5 million in Q4 2025 for Mimedx, up from $254.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $277.5 million in Q4 2025 to a low of $131.0 million in Q2 2022.
  • Historically, Current Assets has averaged $166.3 million across 5 years, with a median of $149.2 million in 2021.
  • Biggest five-year swings in Current Assets: fell 17.25% in 2021 and later soared 47.61% in 2025.
  • Year by year, Current Assets stood at $148.5 million in 2021, then fell by 9.64% to $134.2 million in 2022, then increased by 22.4% to $164.3 million in 2023, then increased by 16.82% to $191.9 million in 2024, then skyrocketed by 44.6% to $277.5 million in 2025.
  • Business Quant data shows Current Assets for MDXG at $277.5 million in Q4 2025, $254.1 million in Q3 2025, and $220.9 million in Q2 2025.